Wednesday, March 27, 2019

Tumor-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer

A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action.

from Top Health News -- ScienceDaily https://ift.tt/2OsEtyH
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Hidden blood molecules show surprising anti-aging power

Scientists have identified new anti-aging compounds produced by a little-studied blood bacterium. These indole metabolites were able to redu...